ArticleAmerican journal of translational research2022

Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.

Liang Min et al.PubMed ↗Full text ↗

No numbers read from the abstract.